{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:27:11Z","timestamp":1773408431110,"version":"3.50.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.juro.2012.08.243","type":"journal-article","created":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T01:15:49Z","timestamp":1348449349000},"page":"1006-1013","source":"Crossref","is-referenced-by-count":21,"title":["Safety and Efficacy of Once Daily Administration of 50 mg Mirodenafil in Patients with Erectile Dysfunction: a Multicenter, Double-Blind, Placebo Controlled Trial"],"prefix":"10.1097","volume":"189","author":[{"given":"Jae Hoon","family":"Chung","sequence":"first","affiliation":[{"name":"Department of Urology, Hanyang University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hyuk","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Urology, Hanyang University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Young","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, Hallym University, Chuncheon, Busan, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Min","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Urology, Kosin University College of Medicine, Busan, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Soo","family":"Lee","sequence":"additional","affiliation":[{"name":"Dong-A University College of Medicine, Busan, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Hyo","family":"Kim","sequence":"additional","affiliation":[{"name":"Dong-A University College of Medicine, Busan, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hyun","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, Cancer Center, Dongnam Institute of Radiological & Medical Science, Busan, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Man","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Urology, Eulji University School of Medicine, Gyeonggi-do, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Wook","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, Hanyang University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.08.243_bib1","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","article-title":"Erectile dysfunction","volume":"342","author":"Lue","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2012.08.243_bib2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.clinthera.2009.06.008","article-title":"Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea","volume":"31","author":"Kim","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.juro.2012.08.243_bib3","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.eururo.2012.02.033","article-title":"A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with alpha-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"61","author":"Gacci","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1743-6109.2005.00118.x","article-title":"Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study","volume":"2","author":"Fisher","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2012.08.243_bib5","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1111\/j.1743-6109.2008.00945.x","article-title":"Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction","volume":"5","author":"Paick","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2012.08.243_bib6","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1185\/03007990802498440","article-title":"Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option","volume":"24","author":"Donatucci","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.juro.2012.08.243_bib7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.juro.2006.10.055","article-title":"Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial","volume":"177","author":"McVary","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib8","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.juro.2006.11.037","article-title":"Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"177","author":"McVary","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib9","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.eururo.2008.01.075","article-title":"A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"53","author":"Stief","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.ijir.3901496","article-title":"Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US","volume":"19","author":"Rajfer","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.juro.2012.08.243_bib11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.juro.2008.06.079","article-title":"Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study","volume":"180","author":"Roehrborn","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.eururo.2009.04.033","article-title":"Effects of once-daily tadalafil on erectile function in men with erectile dysfunction and signs and symptoms of benign prostatic hyperplasia","volume":"56","author":"Porst","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib13","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1464-410X.2010.09204.x","article-title":"A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia","volume":"106","author":"Tamimi","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.08.243_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.eururo.2011.08.005","article-title":"Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial","volume":"60","author":"Porst","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1743-6109.2011.02504.x","article-title":"Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study","volume":"9","author":"Egerdie","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2012.08.243_bib16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.eururo.2011.03.025","article-title":"Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"60","author":"Zhao","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.eururo.2006.02.052","article-title":"Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"50","author":"Porst","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1517\/14656560802678211","article-title":"The impact of daily sildenafil on levels of soluble molecular markers of endothelial function in plasma in patients with erectile dysfunction","volume":"10","author":"Konstantinopoulos","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.juro.2012.08.243_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jpba.2008.11.004","article-title":"Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male rats","volume":"49","author":"Lee","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.juro.2012.08.243_bib20","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1464-410X.2010.09759.x","article-title":"Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"107","author":"Zhao","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.08.243_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00003088-199427050-00005","article-title":"Pharmacokinetic contributions to postantibiotic effects","volume":"27","author":"Zhanel","year":"1994","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.juro.2012.08.243_bib22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/j.1552-4604.1991.tb03686.x","article-title":"Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil","volume":"31","author":"Borin","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.juro.2012.08.243_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1464-410X.2006.06290.x","article-title":"Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review","volume":"98","author":"McMahon","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.08.243_bib24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.eururo.2011.06.037","article-title":"Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"60","author":"Gacci","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.eururo.2005.02.001","article-title":"Erectile dysfunction and lower urinary tract symptoms secondary to BPH","volume":"47","author":"McVary","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1743-6109.2008.01057.x","article-title":"Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA\/Rho-kinase signaling hyperactivation","volume":"6","author":"Morelli","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2012.08.243_bib27","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s11547-009-0449-8","article-title":"Effect of Tadalafil on prostate haemodynamics: preliminary evaluation with contrast-enhanced US","volume":"114","author":"Bertolotto","year":"2009","journal-title":"Radiol Med"},{"key":"10.1016\/j.juro.2012.08.243_bib28","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1464-410X.2010.09698.x","article-title":"Phosphodiesterase 5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review","volume":"107","author":"Laydner","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.08.243_bib29","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.eururo.2012.01.013","article-title":"Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial","volume":"61","author":"Oelke","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.243_bib30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1464-410X.2009.08822.x","article-title":"Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment","volume":"105","author":"Roehrborn","year":"2010","journal-title":"BJU Int"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712049531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712049531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.08.243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T22:55:13Z","timestamp":1651186513000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.08.243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1016\/j.juro.2012.08.243"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.08.243","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717958819.793463373","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}